Drug Topics Nav

PREVIOUS ISSUE NEXT ISSUE
July 2017 Default Cover Image
Articles
Bank Loans Help Keep Pharmacies in their Towns
July 12, 2017By Beth Longware Duff
The needs that small pharmacies have—and how they are being met
In this issue
Big-Box Pharmacy on the Rise
July 12, 2017
Big-box merchandisers, including supermarkets, employ thousands of pharmacists and offer higher-than-average salaries.
Pharmacy Accounting: The Least You Need to Know
July 12, 2017By Scotty Sykes CPA
Daily and monthly aspects of pharmacy accounting and tax preparation and planning can be complex and difficult. Proper pharmacy accounting comes down to making sure your books are current, have integrity, and operate efficiently.
The Impact of a Pharmacist as a Health Coach
July 12, 2017By Christina Tarantola PharmD CHC
A look at the ways coaching your patients can leave them healthier.
Precision Medicine: A New Role for Pharmacists
July 12, 2017By Kathleen Gannon Longo
The biggest innovation in medicine in the last decade (and how to get in on it).
New Board Certifications Show Increasing Complexity of Pharmacy
July 12, 2017By Gail Kalinoski
BPS has been adding more board certifications—but they're not done yet.
Pharmacist Personal Beliefs in the News Again
July 12, 2017By Joan Vos MacDonald
A New Mexico pharmacist's actions brought an ACLU lawsuit.
Cannabis for Credits
July 12, 2017By Jill Sederstrom
Clinical rotation gives students unique view of medical cannabis industry.
A Drug Causes Hundreds of Deaths and Millions of ADEs
July 13, 2017By Nicholas Hamm
An investigation into Actemra (tocilizumab) has uncovered hundreds of serious adverse drug events, but the drug's labeling has not been changed.
Clinical Challenge: What Would You Do?
July 13, 2017By Alexa Vyain PharmD, Amy M. Cheng PharmD, Justin A. Andrade
Preventing drug-drug interactions with HIV ART
FDA Approves First Drug for Sickle Cell in 20 Years
July 13, 2017By Valerie DeBenedette
Endari is only the second FDA-approved sickle cell disease drug.
New Drug Review: Sarilumab
July 13, 2017By Kathryn Wheeler PharmD BCPS
The FDA approved Kevzara for RA patients.
PREVIOUS ISSUE NEXT ISSUE